Activa CRO-Contract Research Organization Contract Research Organization

CRO in Latin America

"Activa Cro is the leading CRO in Latin America."

South American Cro in Latinoamérica

Activa CRO in Latin America

Activa-CRO is a Latin American full-service contract research organization (CRO), based in Buenos Aires Argentina, with operations in Latin America, that provides the biotechnology, pharmaceutical and medical device industry, with a range of services related to clinical development of health products.
The company was founded and is managed by senior professionals in Biotech, Pharmaceutical, Medical Device Development and Regulatory Affairs, with combined decades of experience and knowledge developing clinical research programs.

In 2006, Activa-CRO (South American) was granted ISO 9001: 2000 Standard Quality Certification on: "Control and surveillance on clinical research trial processes for the development of drugs, biological products and medical devices” (Recertified ISO 9001:2008). This certification was issued by Bureau Veritas Certification and accredited by UKAS (Europe), ANAB (North America) and OAA (South America).

Activa-CRO (Clinical Research Organization) Latinoamérica brings an experience from 60+ projects in all clinical phases of development and major therapeutic indications, including Experience Oncology, Hematology, Cardiovascular, Orphan Diseases, CNS, First in Human and Pivotal studies in Medical Devices. Our Clinical Trial Mangers bring an average of 10 years of experience in clinical research operations, ensuring that your project runs smoothly and efficiently.

Activa Cro provides the following capabilities

Advantages of the LATAM Market

Clinical research in Latin America has become an emerging market, with an ever-increasing importance in the field of clinical research including early stages of drug development.
There are many reasons why Latin America can meet the quality standards of any clinical trial. Firstly, local professional working force is well trained, and they are reliable and committed.
Also t Latin American markets relies on an increasing number of inhabitants, who can later on become targets of sale of approved drugs.
Subject tests also show a greater degree of commitment, and drop off rates are lower than in other areas. Patient recruitment time is also usually shorter in most urban areas.
Lastly, demographic distribution is also a plus: over a quarter of the population are under 14 years of age.
Our facilities in Latin America provide the perfect environment for the most advanced research, meeting all along international quality standards. Activa CRO has the experience that over 14 years of practice of clinical trials can provide, and our expertise in Latin America regulations and operational methods are an extra guarantee ensuring a successful completion of our clients clinical study.


+598 97 985 650